Skip to Content
 

News: July, 2019

Cellular soldiers designed to kill cancer cells that get loose during surgery, stop metastasis

Friday, July 26th, 2019

Cellular soldiers created using the body’s own defenses can track down and kill escaping cancer cells during surgeries, preventing metastasis and saving lives, a Vanderbilt University biomedical engineer has discovered, particularly in cases of triple negative breast cancer.

Team’s study reveals details of new DNA repair pathway

Friday, July 26th, 2019

Investigators have discovered how a DNA repair pathway protein shields sites of damage to avoid mutations and maintain genome integrity.

Encephalitis identified as rare toxicity of immunotherapy treatment

Monday, July 22nd, 2019

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

A critical factor for wound healing

Friday, July 19th, 2019

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

Center for Immunobiology grows, bolsters program

Friday, July 19th, 2019

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Hand-held robot points to less invasive prostate surgery

Friday, July 19th, 2019

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.

International Association of Medical Science Educators honors Osheroff

Thursday, July 11th, 2019

Neil Osheroff, PhD, received the Distinguished Career Award for Excellence in Teaching and Educational Scholarship from the International Association of Medical Science Educators (IAMSE).

Vanderbilt vaccine pioneer James Crowe honored with major science prize

Thursday, July 11th, 2019

James Crowe Jr., MD, has been honored by the science and technology company Merck KGaA, Darmstadt, Germany for his contributions to developing new therapeutics and vaccines against some of the world’s deadliest viruses.

Vanderbilt team shows how stomach bug can trigger cancer

Thursday, July 11th, 2019

Researchers have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori to inject a cancer-causing protein into the stomach lining.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.